Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient

被引：6
作者：
Bittner, Aitomi [1 ,2 ,3 ,4 ]
Radke, Josefine [2 ,3 ,4 ,5 ,6 ,7 ]
Eurich, Dennis [2 ,3 ,4 ,8 ]
Wiener, Edzard [9 ]
Denker, Sophy [2 ,3 ,4 ]
Anagnostopoulos, Ioannis [10 ]
Na, Il-Kang [1 ,2 ,3 ,4 ,5 ,11 ,12 ]
Heppner, Frank L. [2 ,3 ,4 ,5 ,7 ,13 ,14 ]
Bullinger, Lars [1 ,2 ,3 ,4 ,5 ,6 ,7 ,15 ]
Schmitt, Clemens A. [1 ,2 ,3 ,4 ,6 ,15 ,16 ]
机构：
[1] Charit Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Berlin Inst Hlth, Berlin, Germany
[5] Berlin Inst Hlth BIH, Berlin, Germany
[6] German Canc Consortium DKTK, Berlin, Germany
[7] Charit Univ Med Berlin, Dept Neuropathol, Berlin, Germany
[8] Charit Univ Med Berlin, Dept Surg, Berlin, Germany
[9] Charit Univ Med Berlin, Inst Neuroradiol, Berlin, Germany
[10] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[11] Expt & Clin Res Ctr ECRC, Berlin, Germany
[12] BIH Ctr Regenerat Therapies, Berlin, Germany
[13] NeuroCure, Cluster Excellence, Berlin, Germany
[14] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany
[15] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany
[16] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Hematol & Oncol, Linz, Austria
来源：
LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 08期
关键词：
D O I：
10.1080/10428194.2021.1889537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2026 / 2029
页数：4
相关论文
共 13 条
  • [1] Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
    Abdel-Wahab, Noha
    Safa, Houssein
    Abudayyeh, Ala
    Johnson, Daniel H.
    Van Anh Trinh
    Zobniw, Chrystia M.
    Lin, Heather
    Wong, Michael K.
    Abdelrahim, Maen
    Gaber, A. Osama
    Suarez-Almazor, Maria E.
    Diab, Adi
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab
    Amjad, Waseem
    Kotiah, Sandy
    Gupta, Ankur
    Morris, Michael
    Liu, Li
    Thuluvath, Paul J.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) : 185 - 187
  • [3] Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review
    Chak, Eric
    Saab, Sammy
    [J]. LIVER INTERNATIONAL, 2010, 30 (09) : 1247 - 1258
  • [4] Targetable genetic features of primary testicular and primary central nervous system lymphomas
    Chapuy, Bjoern
    Roemer, Margaretha G. M.
    Stewart, Chip
    Tan, Yuxiang
    Abo, Ryan P.
    Zhang, Liye
    Dunford, Andrew J.
    Meredith, David M.
    Thorner, Aaron R.
    Jordanova, Ekaterina S.
    Liu, Gang
    Feuerhake, Friedrich
    Ducar, Matthew D.
    Illerhaus, Gerald
    Gusenleitner, Daniel
    Linden, Erica A.
    Sun, Heather H.
    Homer, Heather
    Aono, Miyuki
    Pinkus, Geraldine S.
    Ligon, Azra H.
    Ligon, Keith L.
    Ferry, Judith A.
    Freeman, Gordon J.
    van Hummelen, Paul
    Golub, Todd R.
    Getz, Gad
    Rodig, Scott J.
    de Jong, Daphne
    Monti, Stefano
    Shipp, Margaret A.
    [J]. BLOOD, 2016, 127 (07) : 869 - 881
  • [5] Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review
    Fisher, Juliya
    Zeitouni, Nathalie
    Fan, Weijia
    Samie, Faramarz H.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1490 - 1500
  • [6] Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
    Green, Michael R.
    Rodig, Scott
    Juszczynski, Przemyslaw
    Ouyang, Jing
    Sinha, Papiya
    O'Donnell, Evan
    Neuberg, Donna
    Shipp, Margaret A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1611 - 1618
  • [7] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [8] Liver graft rejection following immune checkpoint inhibitors treatment: a review
    Hu, Bo
    Yang, Xiao-Bo
    Sang, Xin-Ting
    [J]. MEDICAL ONCOLOGY, 2019, 36 (11)
  • [9] Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival
    Kremers, WK
    Devarbhavi, HC
    Wiesner, RH
    Krom, RAF
    Macon, WR
    Habermann, TM
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 1017 - 1024
  • [10] On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation
    Lesokhin, Alexander M.
    Callahan, Margaret K.
    Postow, Michael A.
    Wolchok, Jedd D.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (280)
12